Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Key Market Movers Trainline Raises FullYear Guidance for Second Time in 2024 Signals Strong Travel Demand SpaceX Prospectus Raises Concerns Among Investors BTS and OREO Unveil LimitedEdition Cookie Inspired by Korean Culture and ARMY Fandom Netflixs The Boroughs from Duffer Brothers Falls Short After Strong Start Ukraine Gymnastics Federation Seeks Emergency FIG Congress Over Russian Athlete Reinstatement LendingTree TREE Q1 2026 Earnings Strong EPS Beat Amid Market Uncertainty OSW Q1 2026 Earnings EPS Beats Estimates with 389 Surprise Amid Modest Stock Decline NCNA Q3 2024 Earnings Narrowed Loss Beats Expectations NFGC Q1 2026 Earnings Deep EPS Miss Underscores PreRevenue Stage Challenges Ivanhoe Electric Q1 2026 Earnings WiderThanExpected Loss as Exploration Continues ProCap Financial BRR Drops 85 Key Support Level Under Pressure Monopar Therapeutics MNPR Slips Slightly While Holding Key Technical Levels Black Spade Acquisition III BIII Holds Steady Near 10 as SPAC Awaits Business Combination Ibotta IBTA Gains Momentum Testing Key Resistance Level Latin American Leaders Seek New Housing Finance and Climate Resilience at World Urban Forum 13 Jim Cramer Expresses Disappointment Over Toll Brothers Outlook Lidl Overtakes Morrisons to Become Britains FifthLargest Supermarket SEC Advances Proposal to End Mandatory Quarterly Earnings Reports Backed by Trump Retail Hiring Surge in April Contrasts with Cautious Consumer Signals Trump Pressures Bank of America JPMorgan Over Alleged Conservative Discrimination Swiss Franc and Japanese Yen Strengthen as DeepSeeks AI Model Sparks SafeHaven Demand ANNX Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines on PreRevenue Status Pembina Pipeline PBA Slides 155 as Energy Sector Faces Headwinds Americas CarMart CRMT Slips 182 Approaches Key Support Zone Koppers Holdings KOP Rallies 184 as Stock Approaches Key Resistance Level Grupo Televisa TV Edges Higher Key Levels to Watch After a Slight Rally Ready Capital RC Slides to 178 Support and Resistance Levels in Focus Decoy Therapeutics DCOY Surges 10 as Biotech Momentum Builds AbCellera Biologics ABCL Attempts Recovery Near Support Level